•
Sep 30, 2020

CME Group Q3 2020 Earnings Report

CME Group's financial results for Q3 2020 were reported, showing strong performance in metals, equities, agriculture, and data services businesses.

Key Takeaways

CME Group reported a revenue of $1.1 billion and an operating income of $525 million for Q3 2020. The net income was $412 million, with a diluted earnings per share of $1.15. On an adjusted basis, the net income was $495 million and diluted earnings per share was $1.38.

Metals, equities, agriculture and data services businesses showed strong performance during the third quarter.

The company continued to innovate amid the extreme uncertainty, announcing a number of new products and services across asset classes, including Micro E-mini options and Nasdaq Veles California Water Index futures.

Focus in Q4 remains on adding new value through the migration of BrokerTec onto CME Globex later this year.

The company is providing risk management tools to help global clients as they continue to navigate through this difficult economic environment.

Total Revenue
$1.08B
Previous year: $1.28B
-15.3%
EPS
$1.38
Previous year: $1.9
-27.4%
Average Daily Volume
15.6M
Average Rate Per Contract
$0.716
Gross Profit
$864M
Previous year: $1.05B
-18.0%
Cash and Equivalents
$1.33B
Previous year: $1.21B
+10.1%
Free Cash Flow
$263M
Previous year: $753M
-65.0%
Total Assets
$126B
Previous year: $79.4B
+58.4%

CME Group

CME Group

CME Group Revenue by Segment

Forward Guidance

CME Group remains focused on adding new value through the migration of BrokerTec onto CME Globex later this year, as well as providing risk management tools to help our global clients as they continue to navigate through this difficult economic environment.

Revenue & Expenses

Visualization of income flow from segment revenue to net income